Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cybersecurity Is A ‘Team Sport:’ FDA And MITRE Update Medical Device Cybersecurity Playbook

Executive Summary

In collaboration with FDA, MITRE published an updated playbook for medical device cybersecurity preparedness.

You may also be interested in...



COVID-19 Brings Additional Cybersecurity Challenges To Health Care Sector: Experts

The coronavirus pandemic means more use of telehealth and hospital staff having to work remotely, which increases opportunities for malicious hackers to take advantage of the situation, experts tell Medtech Insight.

US FDA Pushes Further On Cybersecurity Efforts Despite Limited Resources

US FDA unveiled multiple cybersecurity-related initiatives, including two memoranda of understandings to launch information sharing organizations and playbook for health-care delivery organizations. The agency is continuing a multi-front attack in the area, despite limited resources.

WannaCry Cybersecurity Alert Shows Medtech Software Must Look Beyond Quick Fixes

Preventing cyberattacks on medical technology occupies the waking thoughts of device software manufacturers, but the global ransomware episode in mid-May shows that companies must also be alive to threat posed to their provider customers.

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT146058

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel